International Stem Cell Corporation (ISCO)
-OTC Markets 0.24 
0.01(5.24%) Jun 18, 3:47PM EDT
| Prev Close: | 0.25 |
|---|
| Open: | 0.24 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 0.54 |
|---|
| Beta: | 1.21 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.23 - 0.24 |
|---|
| 52wk Range: | 0.16 - 0.45 |
|---|
| Volume: | 112,995 |
|---|
| Avg Vol (3m): | 115,405 |
|---|
| Market Cap: | 26.41M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.10 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- INTERNATIONAL STEM CELL CORP Files SEC form 8-K, Submission of Matters to a Vote of Security HoldersEDGAR Online(Thu, Jun 13)
- Lifeline Skin Care Expands Asian DistributionMarketwired(Tue, Jun 11)
- International Stem Cell Corporation Initiates IND-Enabling Study in Parkinson's Disease ProgramMarketwired(Thu, May 30)
- INTERNATIONAL STEM CELL CORP FinancialsEDGAR Online Financials(Tue, May 21)
- International Stem Cell Corporation to Present at Two Upcoming Investor ConferencesMarketwired(Wed, May 15)
- International Stem Cell Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Tue, May 14)
- International Stem Cell Corporation Announces First Quarter 2013 Financial Results and Provides Business UpdateMarketwired(Tue, May 14)
- INTERNATIONAL STEM CELL CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementsEDGAR Online(Tue, May 14)
- INTERNATIONAL STEM CELL CORP Files SEC form 10-Q, Quarterly ReportEDGAR Online(Mon, May 13)
- International Stem Cell Corporation to Host First Quarter 2013 Financial Results Conference Call at 11:00 a.m. ET on Tuesday, May 14, 2013Marketwired(Thu, May 9)
- International Stem Cell Corporation to Present at American Society of Gene and Cell Therapy 16th Annual MeetingMarketwired(Wed, May 1)
- INTERNATIONAL STEM CELL CORP Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles ofEDGAR Online(Mon, Apr 15)
- Curing Parkinson's: The Alternative Approach - Is There Money To Be Made?at Seeking Alpha(Thu, Apr 4)
- International Stem Cell Management Discusses 2012 Results - Earnings Call Transcriptat Seeking Alpha(Thu, Mar 28)
- International Stem Cell Corporation Announces Fourth Quarter 2012 Financial Results and Provides Business UpdateMarketwired(Wed, Mar 27)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 5.84 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-11)
: | N/A |
|---|
| Quarterly EPS Est
(Jun-11)
: | N/A |
|---|
| Mean Recommendation*: | 3.0 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
International Stem Cell Corporation, a developmental stage biotechnology company, engages in the development and commercialization of therapeutic, biomedical, and cosmeceutical products in the United States and internationally.
View More